American International Group, Inc. Tg Therapeutics, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$13.02 - $21.3 $7,642 - $12,503
-587 Reduced 0.85%
68,341 $1.04 Million
Q4 2023

Feb 13, 2024
BUY
$6.68 - $18.81 $2,979 - $8,389
446 Added 0.65%
68,928 $1.18 Million
Q3 2023

Nov 13, 2023
BUY
$8.36 - $26.5 $20,356 - $64,527
2,435 Added 3.69%
68,482 $572,000
Q2 2023

Aug 04, 2023
BUY
$15.48 - $35.0 $27,229 - $61,565
1,759 Added 2.74%
66,047 $1.64 Million
Q1 2023

May 12, 2023
BUY
$10.23 - $19.34 $13,084 - $24,735
1,279 Added 2.03%
64,288 $966,000
Q4 2022

Feb 10, 2023
SELL
$5.01 - $11.83 $1,147 - $2,709
-229 Reduced 0.36%
63,009 $745,000
Q3 2022

Nov 14, 2022
BUY
$4.57 - $8.4 $4,081 - $7,501
893 Added 1.43%
63,238 $374,000
Q2 2022

Aug 12, 2022
SELL
$3.74 - $10.66 $7,337 - $20,914
-1,962 Reduced 3.05%
62,345 $265,000
Q1 2022

May 13, 2022
SELL
$7.81 - $20.45 $35,355 - $92,577
-4,527 Reduced 6.58%
64,307 $612,000
Q4 2021

Feb 11, 2022
SELL
$15.2 - $35.51 $20,170 - $47,121
-1,327 Reduced 1.89%
68,834 $1.31 Million
Q3 2021

Nov 12, 2021
SELL
$21.78 - $40.45 $36,307 - $67,430
-1,667 Reduced 2.32%
70,161 $2.34 Million
Q2 2021

Aug 13, 2021
SELL
$32.5 - $48.96 $73,027 - $110,013
-2,247 Reduced 3.03%
71,828 $2.79 Million
Q1 2021

May 07, 2021
BUY
$41.61 - $54.3 $144,345 - $188,366
3,469 Added 4.91%
74,075 $3.57 Million
Q4 2020

Feb 12, 2021
BUY
$25.27 - $54.9 $106,285 - $230,909
4,206 Added 6.33%
70,606 $3.67 Million
Q3 2020

Nov 04, 2020
BUY
$18.49 - $27.24 $135,513 - $199,641
7,329 Added 12.41%
66,400 $1.78 Million
Q2 2020

Aug 12, 2020
BUY
$8.9 - $21.84 $71,707 - $175,964
8,057 Added 15.79%
59,071 $1.15 Million
Q1 2020

May 04, 2020
SELL
$7.14 - $15.99 $21,041 - $47,122
-2,947 Reduced 5.46%
51,014 $502,000
Q4 2019

Feb 05, 2020
BUY
$5.1 - $11.2 $11,072 - $24,315
2,171 Added 4.19%
53,961 $599,000
Q3 2019

Nov 08, 2019
BUY
$5.38 - $8.99 $9,678 - $16,173
1,799 Added 3.6%
51,790 $291,000
Q2 2019

Aug 13, 2019
BUY
$6.27 - $8.65 $62,323 - $85,981
9,940 Added 24.82%
49,991 $432,000
Q1 2019

May 06, 2019
SELL
$4.02 - $8.04 $5,221 - $10,443
-1,299 Reduced 3.14%
40,051 $322,000
Q4 2018

Feb 13, 2019
SELL
$3.44 - $5.76 $1,090 - $1,825
-317 Reduced 0.76%
41,350 $170,000
Q3 2018

Nov 09, 2018
BUY
$5.15 - $14.0 $16,098 - $43,764
3,126 Added 8.11%
41,667 $233,000
Q2 2018

Aug 08, 2018
BUY
$12.5 - $15.0 $71,475 - $85,770
5,718 Added 17.42%
38,541 $507,000
Q1 2018

May 07, 2018
SELL
$8.7 - $16.8 $15,355 - $29,652
-1,765 Reduced 5.1%
32,823 $466,000
Q4 2017

Feb 09, 2018
BUY
$7.35 - $12.3 $15,089 - $25,251
2,053 Added 6.31%
34,588 $284,000
Q3 2017

Nov 09, 2017
BUY
$10.0 - $12.7 $325,350 - $413,194
32,535
32,535 $386,000

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
88.3M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email